Summary

Market Summary:
As per Market Research Future analysis, the Japan neurodiagnostics market Size was estimated at 430.0 USD Million in 2024. The Japan neurodiagnostics market is projected to grow from 462.03 USD Million in 2025 to 948.05 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025 - 2035

Market Drivers:
There is a notable increase in awareness regarding mental health issues in Japan, which is driving the neurodiagnostics market. Public campaigns and educational initiatives are encouraging individuals to seek help for mental health conditions, such as depression and anxiety disorders. This heightened awareness is likely to result in a greater demand for neurodiagnostic services, as healthcare providers aim to offer comprehensive assessments for mental health conditions. The market could see a growth rate of around 6% as more individuals seek neurodiagnostic evaluations to better understand their mental health. This trend underscores the importance of integrating neurodiagnostics into mental health care, thereby expanding the market's reach. Investment in research and development (R&D) within Japan's healthcare sector is significantly influencing the neurodiagnostics market. The government and private entities are allocating substantial funds to develop advanced diagnostic technologies, including neuroimaging and electrophysiological techniques. In 2025, R&D spending in the medical technology sector is projected to reach ¥1 trillion, with a notable portion directed towards neurodiagnostics.

Market Segment Analysis:
In the Japan neurodiagnostics market, the distribution of market share among product types reveals that Clinical Diagnostic Instruments hold the largest portion, significantly influencing overall market trends. This dominance can be attributed to the extensive applications in various clinical settings, providing critical insights into neurological conditions. Conversely, Diagnostic Imaging Systems are identified as the fastest-growing segment, driven by technological advancements and an increasing prevalence of neurological disorders. Factors such as the rising demand for early diagnostics and improvement in imaging technologies contribute to the rapid expansion of this segment, enhancing the capabilities of healthcare providers across the region. Clinical Diagnostic Instruments (Dominant) vs. Diagnostic Imaging Systems (Emerging) Clinical Diagnostic Instruments are characterized by their pivotal role in providing accurate and timely diagnoses, often being the first line of assessment in neurological cases.

Regional Analysis:
The neurodiagnostics market in Japan is currently experiencing a notable evolution, driven by advancements in technology and an increasing awareness of neurological disorders. The integration of artificial intelligence and machine learning into diagnostic tools appears to enhance the accuracy and efficiency of neurodiagnostic procedures. Furthermore, the aging population in Japan is likely to contribute to a rising demand for neurodiagnostic services, as age-related neurological conditions become more prevalent. This demographic shift necessitates innovative solutions to address the growing healthcare needs, suggesting a robust future for the neurodiagnostics market. In addition, the Japanese government is actively promoting research and development in the healthcare sector, which may lead to the introduction of novel neurodiagnostic devices and techniques.

Major Players:
The following companies are key participants in the Japan Neurodiagnostics Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook

2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation

3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis

4 SECTION IV: QUANTITATIVE ANALYSIS
Japan Neurodiagnostics Market Segmentation
Neurodiagnostics Product Type Outlook (USD Billion, 2019-2030)
Diagnostic Imaging Systems
Clinical Diagnostic Instruments
Reagents and Consumables
Neurodiagnostics Condition Outlook (USD Billion, 2019-2030)
Neurodegenerative Diseases
Stroke
Epilepsy
Headache Disorders
Sleep Disorders
Others
Japan Neurodiagnostics End User Outlook (USD Billion, 2019-2030)
Hospitals and Surgical Centers
Diagnostic Laboratories and Imaging Centers
Neurology Centers
Ambulatory Care Centers
Research Laboratories and Academic Institutes
Neurodiagnostics SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the neurodiagnostics market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the neurodiagnostics market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Nihon Kohden Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Fujifilm Holdings Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Hitachi Medical Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Olympus Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mizuh
Medical Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Sysmex Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Astellas Pharma Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Terum
Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan NEURODIAGNOSTICS MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY PRODUCT TYPE, 2026-2035 (USD Million)
TABLE 2 BY PRODUCT TYPE, 2026-2035 (USD Million)
TABLE 3 BY CONDITION, 2026-2035 (USD Million)
TABLE 4 BY CONDITION, 2026-2035 (USD Million)
TABLE 5 BY END USER, 2026-2035 (USD Million)
TABLE 6 BY END USER, 2026-2035 (USD Million)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN NEURODIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 3 JAPAN NEURODIAGNOSTICS MARKET ANALYSIS BY CONDITION
FIGURE 4 JAPAN NEURODIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 5 KEY BUYING CRITERIA OF NEURODIAGNOSTICS MARKET
FIGURE 6 RESEARCH PROCESS OF MRFR
FIGURE 7 DRO ANALYSIS OF JAPAN NEURODIAGNOSTICS MARKET
FIGURE 8 DRIVERS IMPACT ANALYSIS: JAPAN NEURODIAGNOSTICS MARKET
FIGURE 9 RESTRAINTS IMPACT ANALYSIS: JAPAN NEURODIAGNOSTICS MARKET
FIGURE 10 SUPPLY / VALUE CHAIN: JAPAN NEURODIAGNOSTICS MARKET
FIGURE 11 JAPAN NEURODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 (% SHARE)
FIGURE 12 JAPAN NEURODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
FIGURE 13 JAPAN NEURODIAGNOSTICS MARKET, BY CONDITION, 2024 (% SHARE)
FIGURE 14 JAPAN NEURODIAGNOSTICS MARKET, BY CONDITION, 2024 TO 2035 (USD Million)
FIGURE 15 JAPAN NEURODIAGNOSTICS MARKET, BY END USER, 2024 (% SHARE)
FIGURE 16 JAPAN NEURODIAGNOSTICS MARKET, BY END USER, 2024 TO 2035 (USD Million)
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS